** Shares of IDT Australia IDT.AX rise 9.5% to A$0.115
** Stock hits its highest level since Nov 13, 2024
** The pharma manufacturer sees 1HFY25 revenue to jump by 82% to A$10.5 mln ($6.57 mln)
** Co says total unaudited quarterly revenue nearly doubles to A$5.3 mln from a year earlier
** Co says growth largely driven by significant increase in Advanced Therapies business
** Stock has gained 4.6%, YTD
($1 = 1.5972 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。